作者：
Thomas P,Hellyer [1]
;
Niall H,Anderson [2]
;
Jennie,Parker [3]
;
Paul,Dark [4]
;
Tina,Van Den Broeck [5]
;
Suveer,Singh [6]
;
Ronan,McMullan [7]
;
Ashley M,Agus [8]
;
Lydia M,Emerson [9]
;
Bronagh,Blackwood [9]
;
Savita,Gossain [10]
;
Tim S,Walsh [11]
;
Gavin D,Perkins [12]
;
Andrew Conway,Morris [13]
;
Daniel F,McAuley [2]
;
A John,Simpson [8]
作者单位：
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. t.p.hellyer@ncl.ac.uk.
[1]
Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK.
[2]
Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
[3]
Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre & Intensive Care Unit, Salford Royal NHS Foundation Trust, Greater Manchester, UK.
[4]
Becton Dickinson Biosciences, Erembodegem, Aalst, Belgium.
[5]
Intensive Care Unit, Chelsea and Westminster Hospital, Imperial College London, London, UK.
[6]
Department of Medical Microbiology, Kelvin Building, The Royal Hospitals, Belfast, UK.
[7]
Northern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK.
[8]
Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
[9]
Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, UK.
[10]
MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
[11]
University of Warwick and Heart of England NHS Foundation Trust, Coventry, UK.
[12]
Division of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
[13]
Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK.
[14]
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
[15]
DOI
10.1186/s13063-016-1594-8
PMID
27669981
发布时间
2022-01-31
换一批
换一批
